Roka Bioscience to Co-Present Industry Webinar – Play FDA for a day
Warren, NJ Sept. 7, 2016 — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, will launch a new technology-based environmental auditing program during a co-presented webcast titled: Play FDA for a day: Criminalization of foodborne illness & what you can do to protect your company.
Webcast topics include:
- Navigating the regulatory environment
- Impact of Whole Genome Sequencing
- Importance of using more accurate pathogen detection technology
- How to self-audit your food facilities to avoid unwanted regulatory or criminal exposure with the support of experienced legal counsel
This free webcast will take place on Wednesday, October 5th at 2:00PM EST.
The webcast will be led by experienced Food Safety Attorney, Shawn Stevens of Food Industry Counsel LLC, who will address the potential personal criminal liability that food manufacturing executives and managers now face under the FDA’s “War on Pathogens”. He will also outline the parameters of the internal auditing process companies should adopt in order to prepare for the pending FDA “swab-a-thons”, and ultimately improve the effectiveness of their preventative control program. “Ensuring your CEO stays out of prison is a great ROI,” said Shawn Stevens, and continued: ”Food company executives and managers need to perform additional testing to see what FDA will find, and then correct it, before FDA arrives in their facility. This is critically important because FDA’s findings can now lead to additional recalls and even criminal prosecution.” stated Shawn K. Stevens.
Roka’s Chief Commercial Officer, Mary Duseau, will launch the self-auditing program that companies can adopt and which is expected to provide the industry with a path for a simple, effective “Play FDA for a Day” audit using advanced technology designed to identify the potential hidden risks in a food processing facility, before it becomes a regulatory or consumer health issue. “We believe that offering a simple package of advanced testing and guidance will be a great value for food processors as they navigate through a changing food safety environment, and we are excited about our strategic relationship with Shawn Stevens, a noted food industry expert, for this initiative,” said Mary Duseau.
Join us for this informative webinar don’t miss out, register today.
About Food Industry Counsel
FOOD INDUSTRY COUNSEL, LLC is the only law firm in the nation that represents only food industry clients – exclusively. For over 15 years, the founding member of FIC, Shawn K. Stevens, has dedicated his practice to representing the food industry. During this period, he has worked globally with a vast array of food industry clients (including the world’s largest food processors, national restaurant chains, and food distributors and grocers) helping them protect their brand by proactively reducing their food safety exposure, complying with complex food safety regulations, coordinating crisis management and recall efforts, and defending high-profile foodborne illness and quality claims. For more information: http://www.foodindustrycounsel.com/
About Roka Bioscience
Roka Bioscience, Inc. is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas® Detection Assays incorporate our advanced molecular technologies and are performed on our “sample-in, result out” Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit http://www.rokabio.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act, as amended (the "Exchange Act"), including those related to our planned service offerings. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions. Any statements contained herein (including, without limitation, statements to the effect that we "believe", "expect", "anticipate", "plan" and similar expressions) that are not statements of historical fact should be considered forward-looking statements. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward looking statements. There are a number of important factors that could cause actual results to differ materially from those indicated by such forward-looking statements. Such factors include those set forth in the company's filings with the Securities and Exchange Commission. We expressly disclaim any obligation to update any forward-looking statements, except as may be required by law. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements represent our estimates and assumptions only as of the date of this press release and, except as required by law, we undertake no obligation to update or review publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.
For Investor or Media Related Inquires Please Contact:
Roka Bioscience, Inc.